Navigation Links
Premier Research Appoints Global Head of Human Resources
Date:9/18/2007

PHILADELPHIA, Sept. 18 /PRNewswire/ -- Premier Research Group plc (AIM: PRG) announces the appointment of W. Scott Keenen as its Vice President, Global Human Resources. Mr. Keenen will be responsible for setting the strategic direction and implementing activities related to maximizing the effectiveness of Premier Research's people and organization in alignment with the company's business strategy.

Dr. Troy McCall, COO, commented: "We are very pleased to have someone of Scott's caliber join our Global Executive Management team. As an already proven internal business partner to global services organizations, he will help us achieve success through the continued attraction of top talent, ongoing development of current staff, and implementation of global processes that ensure we maintain significant focus on what's most important to our company - our people."

Mr. Keenen has 26 years of domestic and international experience across a diverse group of industries including Energy, Technology, Telecommunications and Professional Services. He has demonstrated a successful track record of HR leadership in complex, global, multi-facility, customer focused organizations. Most recently, Mr. Keenen was Global Director Human Resource for inCode Telecom where he executed the HR strategy to grow the organization from less than 200 employees in North America to a global company with over 400 employees in 11 countries. He was responsible for integrating acquisitions and implementing efficiency-enhancing employee recruiting and retention practices. Prior to inCode, Mr. Keenen held positions of increasing responsibility starting as a Field Engineer and moving to HR after cross functional assignments in sales and internal auditing for Schlumberger Ltd. Mr. Keenen received his MBA from Southern Methodist University in Dallas, TX and a BS in Physics from Bates College in Lewiston, ME.

About Premier Research

Premier Research is a leading solutions-driven CRO leveraging our commitment to therapeutic focus and scientific expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leader in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research. Premier Research has 29 offices and operates in more than 30 countries across Europe and North America. They employ a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at well-established network of dedicated clinical sites.


'/>"/>
SOURCE Premier Research Group plc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
3. Control Your siRNA Research
4. Getting Started with MicroRNA Research
5. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
6. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
7. Research Organics
8. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
9. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
10. Research Tools for Analysis of ZAP-70
11. Technical Specifications Accelerating Your Research with the BD FACSCanto High Throughput Sampler Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
Breaking Biology Technology:
(Date:3/20/2017)... Germany , March 20, 2017 At this ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG ... is this year,s CeBIT partner country. At the largest German ... biometrics in use: fingerprint, face and iris recognition as well as DERMALOGĀ“s ... ...
(Date:3/9/2017)... , Australia , March 9, 2017 ... data at the prestigious World Lung Imaging Workshop at ... Andreas Fouras , was invited to deliver the latest ... medicine. This globally recognised event brings together leaders at ... the latest developments in lung imaging. ...
(Date:3/6/2017)... , March 6, 2017 Mintigo ... technology, today announced Predictive Sales Coach TM , ... actionable sales intelligence into Salesforce. This unique AI ... their sales organizations with deep knowledge of their ... for intelligent engagement. Predictive Sales Coach extends Mintigo,s ...
Breaking Biology News(10 mins):